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Association of obstructive sleep apnea 
with hypertension: A systematic review and 
meta-analysis
Background Obstructive sleep apnea (OSA) is a sleep disorder char-
acterized as complete or partial upper airflow cessation during sleep. 
Although it has been widely accepted that OSA is a risk factor for the 
development of hypertension, the studies focusing on this topic re-
vealed inconsistent results. We aimed to clarify the association between 
OSA and hypertension, including essential and medication-resistant 
hypertension.
Methods The Preferred Reporting Items for Systematic Reviews and Me-
ta-Analyses (PRISMA) was followed. PubMed and Embase databases 
were used for searching the relevant studies published up to December 
31, 2016. A quantitative approach of meta-analysis was performed to 
estimate the pooled odds ratio (OR) and 95% confidence interval (CI).
Results Twenty-six studies with 51 623 participants (28 314 men, 
23 309 women; mean age 51.8 years) met inclusion criteria and were 
included in this study. Among them, six studies showed a significant 
association between OSA and resistant hypertension (pooled 
OR = 2.842, 95% CI = 1.703-3.980, P < 0.05). Meanwhile, the combi-
nation of 20 original studies on the association of OSA with essential 
hypertension also presented significant results with the pooled ORs of 
1.184 (95% CI = 1.093-1.274, P < 0.05) for mild OSA, 1.316 (95% 
CI = 1.197-1.433, P < 0.05) for moderate OSA and 1.561 (95% 
CI = 1.287-1.835, P < 0.05) for severe OSA.
Conclusions Our findings indicated that OSA is related to an increased 
risk of resistant hypertension. Mild, moderate and severe OSA are as-
sociated essential hypertension, as well a dose-response manner rela-
tionship is manifested. The associations are relatively stronger among 
Caucasians and male OSA patients.
Obstructive sleep apnea (OSA) is a sleep disorder characterized as complete 
or partial upper airflow cessation during sleep, which mainly results from 
narrowed oropharyngeal or velopharyngeal anatomy [1,2]. OSA is reported 
to affect approximately 17% of American adults [3]. Hereditable dimension 
of craniofacial skeleton, obesity, and aging are considered risk factors for 
OSA, and the lack of neurophysiological regulation on airway dilator mus-
cles also contributes to the causality of OSA [4]. Apart from causing un-
comfortable symptomatology, untreated OSA is widely acknowledged to be 
associated with diabetes, cardiovascular disease and cerebrovascular disease 
[5]. Observational studies have illustrated that the prevalence of OSA is over 
30% among hypertension patients and nearly 80% among resistant hyper-
tensive patients [6,7]. Although the association between OSA and hyper-
tension is considered obvious, the published results regarding this relation-
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ship are not consistent [3]. More than eight studies reported that OSA is not associated with hypertension, 
arousing skepticism of the effect of OSA on the risk for hypertension [2,8]. To our knowledge, the effect 
of continuous positive airway pressure (CPAP) therapy on blood pressure (BP) reduction improves the 
establishment of the causal association of OSA with hypertension and cardiovascular diseases [8]. How-
ever, a recent meta-analysis demonstrated that CPAP intervention does not reduce cardiovascular risk [9]. 
Besides another meta-analysis on CPAP treatment trials found a low reduction of HP (2.6 mm Hg for sys-
tolic BP and 2.0 mm Hg for diastolic BP) among OSA participants [10]. It has been manifested that CPAP 
may not be a sole hypertension intervention option for OSA patients [11]. To determine if OSA plays an 
independent causal role in hypertension, we conducted this systematic review and meta-analysis, and 
synthesized the studies on the association of OSA with essential hypertension and medication-resistant 
hypertension.
MATERIALS AND METHODS
We followed the criteria of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRIS-
MA). The reported PRISMA Checklist is provided in Table S1 in Online Supplementary Document. The 
protocol of this study has been registered in PROSPERO (No. CRD42017064336), available at https://
www.crd.york.ac.uk/PROSPERO/.
Search strategy
The databases of PubMed and Embase were searched for literature published up to December 31, 2016. 
The search strategy was designed as a combination of the following key words: “obstructive sleep apnea” 
or “obstructive sleep apnea syndrome” or “sleep apnea” or “sleep disordered breathing” or “OSA” or “OSAS” 
or “SDB” and “hypertension” or “HTN”. In addition, studies cited in the references at the retrieved articles 
were further screened.
Selection criteria and quality assessment
Two authors independently reviewed the title, abstract and full text of the publications to determine the 
suitability for inclusion. Eligible studies were included based on the following criteria: 1) studies con-
ducted on human populations; 2) studies conducted to investigate the relationships between OSA and 
essential and/or resistant hypertension; 3) case-control studies, case-control comparison of baseline data 
in cohort populations or clinical populations, and cohort studies; 4) odds ratios (OR) and 95% confidence 
interval (CI) available or can be calculated; 5) OSA patients diagnosed with polysomnography, and clas-
sified with apnea-hypopnea index (AHI); 6) studies published in English. We evaluated the methodolog-
ical quality of each study according to the quality assessment scale by reference to PRISMA statement and 
MOOSE guideline (Table S2 and Table S3 in Online Supplementary Document).
Data extraction
Original data were retrieved independently from the eligible publications by two authors. The following 
data were extracted: author’s name, year of publication, ethnicity of participants, type of study design, 
sample size, characteristics of the participants. If results derived from the same population were published 
more than once, the most recent publication or the one with the largest population size was enrolled. If 
a publication investigated the baseline data, and also studied the association of recent-onset hypertension 
with OSA among different numbers of participants through a follow-up, the investigations were treated 
as two independent studies. Data in all subgroups were collected when the authors reported results with 
age or gender stratification. The adjusted ORs were extracted from articles.
Statistical analysis
All statistical analyses were performed with the Stata14.0 software (Stata Corp, College Station, TX, USA). 
The pooled ORs and 95% CIs were calculated to assess the strength of the association between OSA and 
hypertension. Q test and I2 statistic were used to evaluate heterogeneity across the involved studies. When 
I2<50% and P > 0.10, the fixed effect model was used to combine data sets. Otherwise, the random effect 
model was applied. Moreover, we conducted subgroup meta-analysis based on ethnicity of the popula-
tion when heterogeneity was ultra (I2>50% or P < 0.10). To assess the robustness of the combined results 
and evaluate the effect of individual studies on this meta-analysis, we carried out sensitivity analysis by 
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removing each study one at a time. Subsequently, the publication bias was assessed by the Funnel Plot 
analysis, and Egger’s regression asymmetry test was further complemented. The Trim and Fill method was 
used to adjust the significant publication bias.
RESULTS
Eligible studies
Our initial screen returned 15 031 publications in English, of which 4314 were from Pubmed and 10 717 
were from Embase. YZ and WY independently excluded 13 846 ineligible articles through reviewing the 
titles, leaving 1185 articles for further abstract review. Among them, 26 publications with 51 623 partici-
pants (28 314 men, 23 309 women; mean age 51.8 years) met all the inclusion criteria and were enrolled 
in meta-analysis [1,2,8,12-34]. Among those 1 159 publications excluded at the last round: 365 were du-
plicate articles, 311 studies did not refer to OSA or 
hypertension according to the current definitions, 
167 were not original studies, 42 studies were not 
designed as required method, 73 studies did not 
have appropriate diagnostic criteria for OSA pa-
tients, 38 studies investigated other types of hyper-
tension, and 163 were not human-based research. 
The flowchart for the process of screening articles is 
shown in Figure 1. Among all the enrolled publi-
cations, 21 articles reported case-control compari-
son in cross-sectional studies or baseline data of co-
hort studies [1,2,12-18,20,22-32], Four were 
prospective studies [19,21,33,34], and one article 
reported both a baseline data comparison and a pro-
spective study [8]. In terms of the study topics, six 
studies investigated the relationship between OSA 
and resistant hypertension [1,12-16], and 20 stud-
ies investigated the association of OSA with essential 
hypertension [2,8,17-34]. Individual characteristics 
of overall studies are summarized in Table 1 and 
Table S4 in Online Supplementary Document.
Association between OSA and resistant hypertension
We included six studies that explored the relationship between OSA and resistant hypertension [1,12-
16], with five studies conducted among Caucasians and one study was among Asians. The synthesized 
results showed that OSA was significantly associated with resistant hypertension with a pooled OR of 
2.842 (95% CI = 1.703-3.980, P < 0.05) (Figure 2 and Table 2), which indicated that OSA participants 
Figure 1. Flowchart of the study selection.
Figure 2. Forest plot of the 
association between resistant 
hypertension and obstructive 
sleep apnea (OSA).
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had an extra 1.842-fold risk for resistant hypertension prevalence compared to non-OSA participants. 
Subgroup analysis exposited that this association was more outstanding among Caucasian populations 
(OR = 4.406, 95% CI = 1.835-6.977).
The heterogeneity test showed no significant heterogeneity generated across all primary studies (I2 = 0%, 
Q = 2.23, P = 0.816).
Association between OSA and essential hypertension
Twenty studies investigated the relationship between OSA and essential hypertension [2,8,17-34]. Among 
them, 16 studies classified OSA patients into three grades based on AHI their scores, which were mild 
OSA (AHI>5), moderate OSA (AHI>15) and severe OSA (AHI>30). Since natural differences exists be-
tween mild OSA, moderate OSA and severe OSA, results were interpreted separately. As shown in Table 
2 and Figures 3 to 5, essential hyperten-
sion was significantly associated with 
OSA, in terms of mild OSA (OR = 1.184, 
95% CI = 1.093-1.274, P < 0.05), moder-
ate OSA (OR = 1.316, 95% CI = 1.198-
1.434, P < 0.05), and severe OSA 
(OR = 1.561, 95% CI = 1.287-1.835, 
P < 0.05). These results showed the trend 
of that the more serious OSA is, the high-
er hypertension risk occurs. Subgroup 
analyses were conducted based on study 
design (prospective/non-prospective) and 
ethnicity. As shown in Table 2, no signif-
icant results were found in studies with 
prospective study design, which outlined 
the pooled ORs (95% CIs) of 1.038 
(0.808-1.267) for mild OSA, 1.224 
(0.917-1.530) for moderate OSA, and 
1.505 (0.998 – 2.013) for severe OSA. The 
Table 2. Meta-analysis of association between OSA and hypertension
tYpe of htN CAtegorY of osA subgroup
effeCt size heterogeNeitY test
Pooled OR 95% CI P I2 (%) Q P
Resistant HTN OSA/non-OSA Asian 2.460 1.500-4.040 <0.05 - - -
OSA/non-OSA Caucasian 4.406 1.835-6.977 <0.05 0 0.47 0.977
OSA/non-OSA Overall 2.842 1.703-3.980 <0.05 0 2.23 0.816
Essential HTN Mild OSA Prospective 1.038 0.808-1.267 >0.05 64.8 5.69 0.058
Mild OSA Non-prospective 1.210 1.112-1.309 <0.05 0 3.60 0.825
Mild OSA Overall 1.184 1.093-1.274 <0.05 10.1 11.13 0.348
Moderate OSA Caucasian 1.315 1.197-1.433 <0.05 8.0 16.30 0.362
Moderate OSA Prospective 1.224 0.917-1.530 >0.05 12.6 3.43 0.329
Moderate OSA Non-prospective 1.332 1.204-1.456 <0.05 5.4 12.69 0.392
Moderate OSA Overall 1.316 1.198-1.434 <0.05 3.2 16.53 0.416
Severe OSA Caucasian 1.549 1.275-1.824 <0.05 0 7.49 0.586
Severe OSA Prospective 1.505 0.998-2.013 >0.05 0 1.00 0.608
Severe OSA Non-prospective 1.584 1.258-1.909 <0.05 10.2 7.80 0.351
Severe OSA Overall 1.561 1.287-1.835 <0.05 0 8.86 0.546
Essential HTN OSA/non-OSA* Asian 1.583 1.160-2.007 <0.05 0 0.32 0.850
OSA/non-OSA* Caucasian 1.928 1.600-2.256 <0.05 47.0 7.55 0.110
OSA/non-OSA* Prospective 1.475 1.035-1.914 <0.05 0 0.02 0.881
OSA/non-OSA* Non-prospective 1.972 1.651-2.294 <0.05 19.8 6.23 0.284
OSA/non-OSA* Overall 1.799 1.539-2.058 <0.05 26.0 9.46 0.221
HTN – hypertension, OSA – obstructive sleep apnea, OR – odds ratio; CI – confidence interval
*Meta-analysis of six studies only divided subjects into OSA and non-OSA groups.
Figure 3. Forest plots of the association between essential hypertension and mild 
obstructive sleep apnea (OSA).
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heterogeneity test illustrated that I2 values 
were 10.1% (P = 0.348) in mild OSA, 3.2% 
(P = 0.416) in moderate OSA, and 0% 
(P = 0.546) in severe OSA meta-analyses, 
indicating no significant heterogeneity in 
each group.
For the seven studies dividing participants 
only into OSA and non-OSA groups 
[8,24,26,28,29,31,34], the pooled OR 
was 1.799 (95% CI = 1.539-2.058, 
P < 0.05), demonstrating that OSA was as-
sociated with essential hypertension (Fig-
ure S1 and Table S2 in Online Supple-
mentary Document). The subgroup 
analysis based on ethnicity showed signif-
icant results among Asians (OR = 1.583, 
95% CI = 1.160-2.007) and Caucasians 
(OR = 1.928, 95% CI = 1.600-2.256). Ad-
ditionally, no significant heterogeneity was 
found (I2 = 26.0%, P = 0.221). Four studies 
in the three articles reported the relation-
ship between OSA and essential hyperten-
sion among male participants [2,8,33]. 
The combined result of these four studies 
suggested that the association between 
OSA and essential hypertension was rela-
tively stronger among males (OR = 1.698, 
95% CI = 1.319-2.077).
Publication bias
The funnel plot analysis, followed by 
Egger’s test, was applied to detect the po-
tential publication bias. Significant publi-
cation bias existed in the meta-analyses of 
moderate OSA and severe OSA partici-
pants, and the meta-analysis of resistant 
hypertension (Table 3 and Figures S7-S11 
in Online Supplementary Document). 
The Trim and Fill analysis was performed 
to eliminate the effect of publication bias 
on meta-analysis. As shown in Table 3 and 
Figures S12-S14 in Online Supplementa-
ry Document, the pooled ORs (95% CIs) 
were 1.327 (1.222-1.441) for moderate 
OSA and 1.593 (1.369-1.853) for severe 
OSA meta-analyses, and 1.575 (1.117-
2.221) for resistant hypertension.
Figure 5. Forest plots of the association between essential hypertension and severe 
obstructive sleep apnea OSA).
Figure 4. Forest plots of the association between essential hypertension and 
moderate obstructive sleep apnea (OSA).
Table 3. Analysis on publication bias and results of Trim and Fill method analysis
tYpe of htN CAtegorY of osA
egger’s test triM ANd fill Method ANAlYsis
t P Pooled OR 95% CI P
Resistant HTN OSA/non-OSA 2.36 0.078 1.575 1.117-2.221 0.010
Essential HTN Mild OSA 0.92 0.380 1.187 1.103-1.276 <0.001
Essential HTN Moderate OSA 3.91 0.001 1.327 1.222-1.441 <0.001
Essential HTN Severe OSA 1.98 0.079 1.593 1.369-1.853 <0.001
Essential HTN OSA/non-OSA 0.87 0.420 1.356 1.184-1.554 <0.001
HTN – hypertension, OSA – obstructive sleep apnea, OR – odds ratio, CI – confidence interval
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Sensitivity analysis
To evaluate the robustness of the results, sensitivity analyses were undertaken by sequentially removing 
each study. Consequently, no obvious change was generated on omission of any individual study (Figure 
S2-S6 in Online Supplementary Document), confirming that the results of our meta-analyses were sta-
ble. This coincided with the results of heterogeneity tests.
DISCUSSION
This systematic review and meta-analysis was conducted in an effort to clarify the association between 
OSA and hypertension, including both essential and resistant hypertension. Our findings suggest that 
OSA confers a significant association with both essential and resistant hypertension. Moreover, OSA is 
associated with mild OSA, moderate OSA and severe OSA with a stepwise increased degree.
OSA are acknowledged to be associated with hypertension [6,7]. Nevertheless, the potential mechanisms 
underlying the associations have not been well elucidated. Several potential explanations may help us to 
understand the association of OSA and hypertension. OSA induces intermittent hypoxemia, similarly to 
hypoxia/reperfusion injury, and causes oxidative stress, leading to dysfunction of vascular endothelium 
[35]. Meanwhile, excessive outflow of sympathetic vasoconstrictor together with diminished nitric oxide 
bioavailability plays a role in blood pressure elevation [36,37]. In addition, episodes of OSA up-regulate 
sympathetic excitation which acts on the chemoreflex and may consequently result in hypertension 
[10,38]. In clinical observations, sympathetic nervous activity, reflected by 24-hour urinary catecholamine 
excretion, is increased in individuals with sleep-disordered breathing [39]. The data from relevant sur-
veys revealed that the prevalence rate of OSA is 70-83% in resistant hypertensive patients [40]. It is also 
suggested that untreated OSA may lead to reduced effectiveness of medications through pharmacokinet-
ic or chronotherapeutic effects, activating a pathway of resistance to antihypertensive drugs [1]. In the 
present study, we found that OSA strongly predisposes to resistant hypertension by combining six rele-
vant studies. The pooled OR of the causal association in Caucasians is 4.406, which indicates Caucasians 
with OSA suffer more from uncontrolled hypertension.
OSA is also considered to be associated with essential hypertension and the consequences of cardiovas-
cular diseases. However, the results are not entirely consistent, meanwhile more than eight studies have 
generated non-significant results [2,8,13,17,20,22-23,33]. This meta-analysis, involving 20 original stud-
ies in 19 articles, demonstrates that OSA increases the risk of essential hypertension in a dose-response 
manner. Although the dose-response meta-analysis has not been conducted owing to the lack of current 
available data, the trend of pooled ORs shows obviously that the more serious OSA is, the higher hyper-
tension risk occurs.
Gender is indispensable factor in the analysis of demographic data. Nonetheless, seldom studies reported 
the association between OSA and hypertension in specific gender. O’Connor et al. reported that female 
patients with moderate and severe OSA have higher prevalence of essential hypertension than male [33], 
while, Nieto et al reported a lower OR in severe OSA women before [2]. After combining four studies re-
ported in three articles [8,29,31], our finding enlightens that men suffer from higher incidence of essen-
tial hypertension than women, as well the association in Caucasians is greater than that in Asians. These 
differences may be explained by the larger proportion of overweight and obesity among Caucasians and 
also among men [18]. This finding is consistent with a recent study by Cano-Pumarega et al., despite the 
fact that their study did not diagnose OSA with polysomnography and AHI [41]. Regarding ethnic sub-
group analysis, the different results may subject to genetic backgrounds, environmental factors and ge-
netic-environmental interaction [42,43].
Heterogeneity may result from diversity of clinical study design or statistical methodology, and the detec-
tion of heterogeneity is essential for meta-analysis. No significant heterogeneity was found in the present 
study, indicating high compatibility of our results. Care must be taken in the adjustment of potential con-
founding factors in the statistical analysis of clinical studies. Obviously, obesity and age are both contrib-
uting factors to OSA and hypertension. Although investigators suggested that the impact of body mass 
index (BMI) on OSA is quite modest and adjustment for BMI might be an over-adjustment [2,32], we 
have synthesized the OR adjusted for both age and BMI in order to estimate the risk more precisely.
Publication bias, a critical issue in systematic review, mainly results from the tendency that studies with 
positive results are more likely to be published than those with negative findings. Significant publication 
V
IE
W
PO
IN
TS
Hou et al.
PA
PE
RS
June 2018  •  Vol. 8 No. 1 •  010405 8 www.jogh.org •  doi: 10.7189/jogh.08.010405
Acknowledgements: This study was supported by the grants from the Teachers’ Training Project of Taishan 
Medical University, the National Natural Science Foundation of China (No. 81372586, 81370083, 81273170), 
and Shandong Provincial Natural Science Foundation, China (No. ZR2017MH100). We thank Enoch Odame 
Anto, Edith Cowan University, Australia for his English editing on this manuscript.
Authorship declaration: HH, WX and WW conceived and designed the study. YZ, WY, and JD searched the 
literature, reviewed the references, and collected the data. HD, XX and JD contributed to the professional re-
view of medical approaches in the publications. HH and HD analyzed the data. HH, XX, and WW contributed 
to the writing of the manuscript. All authors read and approved the final manuscript.
Ethics approval: Not applicable.
Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.
org/coi_disclosure.pdf (available upon request from the corresponding author) and declare no conflicts of in-
terest.
R
E
FE
R
E
N
C
E
S
  1  Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, et al. Association of severe obstructive sleep apnea and el-
evated blood pressure despite antihypertensive medication use. J Clin Sleep Med. 2014;10:835-43. Medline:25126027
  2  Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep - disordered breathing, sleep ap-
nea, and hypertension in a large community - based study. Sleep Heart Health Study. JAMA. 2000;283:1829-36. Med-
line:10770144 doi:10.1001/jama.283.14.1829
  3  Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive 
sleep apnea and risk of hypertension. JAMA. 2012;307:2169-76. Medline:22618924 doi:10.1001/jama.2012.3418
  4  Dempsey JA. 1, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47-112. 
Medline:20086074 doi:10.1152/physrev.00043.2008
  5  Friedman O, Logan AG. The price of obstructive sleep apnea - hypopnea: hypertension and other ill effects. Am J Hy-
pertens. 2009;22:474-83. Medline:19265785 doi:10.1038/ajh.2009.43
  6  Muxfeldt ES, Margallo V, Costa LM, Guimara˘es G, Cavalcante AH, Azevedo JC, et al. Effects of continuous positive air-
way pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant 
hypertension: a randomized controlled trial. Hypertension. 2015;65:736-42. Medline:25601933 doi:10.1161/HYPER-
TENSIONAHA.114.04852
bias exists in our meta-analyses of moderate OSA, severe OSA and essential hypertension. To reduce po-
tential confounding of publication bias, we carried out the Trim and Fill analysis. According to the results 
of Trim and Fill analysis, the pooled ORs remained statistically significant for the association between 
moderate OSA and essential hypertension, the association between severe OSA and essential hyperten-
sion, as well as the association between OSA and resistant hypertension.
Comparing to low specificity of sleep questionnaires, AHI is an accurate parameter for determining OSA 
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